DIVA Laboratories, Ltd. (4153.TWO)

TWD 38.75

(-1.77%)

Long Term Debt Summary of DIVA Laboratories, Ltd.

  • DIVA Laboratories, Ltd.'s latest annual long term debt in 2023 was - TWD , down -100.0% from previous year.
  • DIVA Laboratories, Ltd.'s latest quarterly long term debt in 2024 Q2 was 3.73 Million TWD , down 0.0% from previous quarter.
  • DIVA Laboratories, Ltd. reported annual long term debt of 153 Thousand TWD in 2022, down -45.94% from previous year.
  • DIVA Laboratories, Ltd. reported annual long term debt of 283 Thousand TWD in 2021, down -30.98% from previous year.
  • DIVA Laboratories, Ltd. reported quarterly long term debt of - TWD for 2024 Q3, down 0.0% from previous quarter.
  • DIVA Laboratories, Ltd. reported quarterly long term debt of 4.34 Million TWD for 2024 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of DIVA Laboratories, Ltd. (2023 - 2019)

Historical Annual Long Term Debt of DIVA Laboratories, Ltd. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 - TWD -100.0%
2022 153 Thousand TWD -45.94%
2021 283 Thousand TWD -30.98%
2020 410 Thousand TWD 0.0%
2019 - TWD 0.0%

Peer Long Term Debt Comparison of DIVA Laboratories, Ltd.

Name Long Term Debt Long Term Debt Difference
BIONET Corp. 6.03 Million TWD 100.0%
Genetics Generation Advancement Corp. 10.34 Million TWD 100.0%
Welgene Biotech Co.,Ltd. 118.97 Million TWD 100.0%
Puriblood Medical Co., Ltd. 43.7 Million TWD 100.0%
TFBS Bioscience Inc. 101.84 Million TWD 100.0%